Sangamo Therapeutics (SGMOQ) Net Cash Flow Growth (5y) (2015 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Net Cash Flow Growth (5y) (2015 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 40.39% |
| Sep 30, 2025 | 46.21% |
| Jun 30, 2025 | -51.32% |
| Mar 31, 2025 | -40.31% |
| Sep 30, 2024 | 19.63% |
| Jun 30, 2024 | -24.30% |
| Mar 31, 2024 | 16.61% |
| Dec 31, 2023 | -20.33% |
| Sep 30, 2023 | -16.80% |
| Jun 30, 2023 | -19.22% |
| Mar 31, 2023 | -3.38% |
| Dec 31, 2022 | -26.29% |
| Sep 30, 2022 | 10.25% |
| Jun 30, 2022 | -15.46% |
| Mar 31, 2022 | -75.10% |
| Dec 31, 2021 | 18.57% |
| Sep 30, 2021 | -14.06% |
| Jun 30, 2021 | 34.07% |
| Mar 31, 2021 | 26.12% |
| Dec 31, 2020 | -41.30% |